Seaport Therapeutics

Seaport Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel neuropsychiatric medicines. It utilizes its proprietary Glyph™ technology platform to enhance oral bioavailability and address limitations in existing treatments. The company's pipeline includes several investigational antidepressants and anxiolytics.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $100M

Date: 09-Apr-2024

Investors: ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, PureTech Health

Markets: Biopharmaceutical, Neuropsychiatry, Biotechnology, Pharmaceutical, Therapeutics, HealthTech, Drug Discovery

HQ: Boston, Massachusetts, United States

Founded: 2024

Website: https://seaporttx.com/

LinkedIn: https://www.linkedin.com/company/seaport-therapeutics

Twitter: https://twitter.com/SeaportTx

Instagram: